Literature DB >> 11560961

Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity.

T Kikuchi1, R G Crystal.   

Abstract

Macrophage-derived chemokine (MDC) is a potent chemoattractant for antigen-specific T lymphocytes. We hypothesized that Adenovirus- (Ad-) transduced dendritic cells (DCs) overexpressing MDC would enhance the T cell-mediated humoral immune response specific for antigens presented by the DC. We challenged two strains of mice with lethal Pseudomonas aeruginosa infection 3 weeks after immunization with AdMDC-modified DCs pulsed with heat-killed P. aeruginosa. MDC-expressing DCs specifically attracted T lymphocytes and preserved typical DC surface phenotypes without growth factors in vitro. Mice immunized with AdMDC/Pseudomonas/DCs developed high levels of serum anti-Pseudomonas Ab's and were protected from a lethal respiratory challenge with Pseudomonas. The in vivo protective immunity required CD4(+) T cells, B cells, and IL-4, but not CD8(+) T cells and IL-12. AdMDC/DCs pulsed with Pseudomonas yielded significant but not absolute cross-protection against different strains of P. aeruginosa. Pseudomonas-pulsed AdMDC/DCs protected mice from Pseudomonas but not Escherichia coli and vice versa; this microbe-specific protection correlated with microbe-specific induction of CD4(+) T cell proliferation and IL-4 secretion. Based on these observations, AdMDC-modified DCs pulsed with a killed bacteria may be a useful approach to vaccination against infectious disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11560961      PMCID: PMC200925          DOI: 10.1172/JCI11564

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

Review 1.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

Review 2.  Human gene therapy.

Authors:  W F Anderson
Journal:  Nature       Date:  1998-04-30       Impact factor: 49.962

3.  The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4.

Authors:  T Imai; M Baba; M Nishimura; M Kakizaki; S Takagi; O Yoshie
Journal:  J Biol Chem       Date:  1997-06-06       Impact factor: 5.157

4.  Inhibition of HIV-1 infection by the beta-chemokine MDC.

Authors:  R Pal; A Garzino-Demo; P D Markham; J Burns; M Brown; R C Gallo; A L DeVico
Journal:  Science       Date:  1997-10-24       Impact factor: 47.728

5.  Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4.

Authors:  T Imai; D Chantry; C J Raport; C L Wood; M Nishimura; R Godiska; O Yoshie; P W Gray
Journal:  J Biol Chem       Date:  1998-01-16       Impact factor: 5.157

6.  Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.

Authors:  F Sallusto; D Lenig; C R Mackay; A Lanzavecchia
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

7.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

8.  Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells.

Authors:  R Godiska; D Chantry; C J Raport; S Sozzani; P Allavena; D Leviten; A Mantovani; P W Gray
Journal:  J Exp Med       Date:  1997-05-05       Impact factor: 14.307

9.  Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.

Authors:  W Song; H L Kong; H Carpenter; H Torii; R Granstein; S Rafii; M A Moore; R G Crystal
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307

10.  Effect of immunisation with Pseudomonas aeruginosa on gut-derived sepsis in mice.

Authors:  T Matsumoto; K Tateda; S Miyazaki; N Furuya; A Ohno; Y Ishii; Y Hirakata; K Yamaguchi
Journal:  J Med Microbiol       Date:  1998-04       Impact factor: 3.196

View more
  9 in total

1.  Involvement of fractalkine/CX3CL1 expression by dendritic cells in the enhancement of host immunity against Legionella pneumophila.

Authors:  Toshiaki Kikuchi; Sita Andarini; Hong Xin; Kazunori Gomi; Yutaka Tokue; Yasuo Saijo; Tasuku Honjo; Akira Watanabe; Toshihiro Nukiwa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Salmonella enterica Serovar Typhimurium infection of dendritic cells leads to functionally increased expression of the macrophage-derived chemokine.

Authors:  Guo Fu; Odilia L C Wijburg; Paul U Cameron; Jason D Price; Richard A Strugnell
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

3.  Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.

Authors:  Yuhuan Zheng; Zhen Cai; Siqing Wang; Xiang Zhang; Jianfei Qian; Sungyoul Hong; Haiyan Li; Michael Wang; Jing Yang; Qing Yi
Journal:  Blood       Date:  2009-08-26       Impact factor: 22.113

4.  A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.

Authors:  Eric T Weimer; Haiping Lu; Nancy D Kock; Daniel J Wozniak; Steven B Mizel
Journal:  Infect Immun       Date:  2009-04-06       Impact factor: 3.441

5.  OX40 ligand expressed by DCs costimulates NKT and CD4+ Th cell antitumor immunity in mice.

Authors:  Jamal Zaini; Sita Andarini; Minoru Tahara; Yasuo Saijo; Naoto Ishii; Kazuyoshi Kawakami; Masaru Taniguchi; Kazuo Sugamura; Toshihiro Nukiwa; Toshiaki Kikuchi
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

6.  The immunity of splenic and peritoneal F4/80(+) resident macrophages in mouse mixed allogeneic chimeras.

Authors:  Guangwei Liu; Haixia Ma; Lingling Jiang; Jianxia Peng; Yong Zhao
Journal:  J Mol Med (Berl)       Date:  2007-05-31       Impact factor: 4.599

7.  Differential Effects of Naja naja atra Venom on Immune Activity.

Authors:  Jian-Qun Kou; Rong Han; Yin-Li Xu; Xiao-Lan Ding; Shu-Zhi Wang; Cao-Xin Chen; Hong-Zhang Ji; Zhi-Hui Ding; Zheng-Hong Qin
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-12       Impact factor: 2.629

8.  Probiotic Lactobacillus johnsonii BS15 Improves Blood Parameters Related to Immunity in Broilers Experimentally Infected with Subclinical Necrotic Enteritis.

Authors:  Hesong Wang; Xueqin Ni; Xiaodan Qing; Lei Liu; Jinge Xin; Min Luo; Abdul Khalique; Yan Dan; Kangcheng Pan; Bo Jing; Dong Zeng
Journal:  Front Microbiol       Date:  2018-01-30       Impact factor: 5.640

9.  Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.

Authors:  Lucia Peluso; Cristiana de Luca; Silvia Bozza; Antonio Leonardi; Gloria Giovannini; Alfonso Lavorgna; Gaetano De Rosa; Massimo Mascolo; Loredana Ortega De Luna; Maria Rosaria Catania; Luigina Romani; Fabio Rossano
Journal:  BMC Microbiol       Date:  2010-01-13       Impact factor: 3.605

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.